Clougherty, J. E., Kinnee, E. J., Cardet, J. C., Mauger, D., Bacharier, L., Beigelman, A., … Holguin, F. (2021). Geography, generalisability, and susceptibility in clinical trials. Lancet Respir Med, 9(4), 330–332. https://doi.org/10.1016/S2213-2600(21)00046-1

Clougherty, Jane E., Ellen J. Kinnee, Juan Carlos Cardet, David Mauger, Leonard Bacharier, Avraham Beigelman, Kathryn V. Blake, et al. “Geography, generalisability, and susceptibility in clinical trials.” Lancet Respir Med 9, no. 4 (April 2021): 330–32. https://doi.org/10.1016/S2213-2600(21)00046-1.

Clougherty JE, Kinnee EJ, Cardet JC, Mauger D, Bacharier L, Beigelman A, et al. Geography, generalisability, and susceptibility in clinical trials. Lancet Respir Med. 2021 Apr;9(4):330–2.

Clougherty, Jane E., et al. “Geography, generalisability, and susceptibility in clinical trials.” Lancet Respir Med, vol. 9, no. 4, Apr. 2021, pp. 330–32. Pubmed, doi:10.1016/S2213-2600(21)00046-1.

Clougherty JE, Kinnee EJ, Cardet JC, Mauger D, Bacharier L, Beigelman A, Blake KV, Cabana MD, Castro M, Chmiel JF, Covar R, Fitzpatrick A, Gaffin JM, Gentile D, Israel E, Jackson DJ, Kraft M, Krishnan JA, Kumar HV, Lang JE, Lazarus SC, Lemanske RF, Lima J, Martinez FD, Morgan W, Moy J, Myers R, Naureckas ET, Ortega VE, Peters SP, Phipatanakul W, Pongracic JA, Ross K, Sheehan WJ, Smith LJ, Solway J, Sorkness CA, Wechsler ME, Wenzel S, White SR, Holguin F. Geography, generalisability, and susceptibility in clinical trials. Lancet Respir Med. 2021 Apr;9(4):330–332.